Monday, 24 June 2024

GE invests in infection control technology

25 June 2012 | News | By BioSpectrum Bureau

GE invests in infection control technology

The investment in Nanosonics is aimed at developing Trophon EPR further

The investment in Nanosonics is aimed at developing Trophon EPR further

Singapore: Global healthcare company GE has invested $7.5 million in Australia-based Nanosonics, a leader in the development of innovative technology for infection control, to further develop and distribute Trophon EPR, an ultrasound transducer disinfecting system. The investment is being made through the GE healthymagination Fund, which makes investments in healthcare technology companies.

"Hospital acquired infections (HAIs) have increased by 36% in the last 20 years and are consuming more healthcare dollars each year," said Ron Weinberger, Managing Director of Nanosonics. "In the ultrasound market, sonographers see over ten patients a day, resulting in an increased need to disinfect the ultrasound transducer thoroughly between patients. Nanosonics has developed Trophon EPR, an innovative ultrasound disinfecting system, that we feel will significantly lower the risk of HAIs among patients."

Realizing there was a significant need to address transducer disinfection, GE Healthcare worked with Australia-based Nanosonics in 2006 to support the validation of the Trophon EPR. After a few years of extensive research, development and testing, Trophon received FDA approval in 2011 and was sold to customers in the US, Canada and Europe. Currently, Trophon is installed at more than 800 customer sites globally.

"When patients get scanned, they deserve full assurance that the equipment being used is safe and clean. The Trophon technology achieves that - and revolutionizes infection control processes as we know it," said Dr Weinberger.

"Nanosonics has built an attractive business with an extraordinary product," said Michael Ackland, President and CEO of GE Healthcare Australia & New Zealand. "We believe the continued collaboration with Nanosonics will help serve our healthcare customers better, complementing GE's suite of ultrasound technologies, software and services. By expanding our sales footprint in Japan as well as in the existing locations such as the US, Canada and Europe, GE will help customers improve their overall quality in ultrasound processes.

"We're delighted to be investing in a great Australian company and to help bring this unique technology to the rest of the world," said Mr Ackland.

Sign up for the editor pick and get articles like this delivered right to your inbox.

Editors Pick
+Country Code-Phone Number(xxx-xxxxxxx)


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account